Entero Therapeutics Inc (ENTO)

$2.99 +0.15 (5.28%)
Market Cap 4.75M
Revenue (ttm) 0.00
Net Income (ttm) -18.06M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.01
Volume 896,800
Avg Vol 224,766
Day's Range N/A - N/A
Shares Out 1.59M
Stochastic %K 40%
Beta 1.19
Analysts Hold
Price Target $36.00

Company Profile

Entero Therapeutics, Inc. designs and develops an artificial intelligence (AI)-driven software and device platform that enables utilities, retailers, and large power users to manage load and distributed energy resources. The company's Aggregation Management Platform leverages IoT, AI/ML, and edge analytics to forecast, optimize, and dispatch flexible demand. The company also engages in the research and development of targeted and non-systemic therapies for the treatment of patients with gastroin...

Industry: Biotechnology
Sector: Healthcare
Address:
91 George St, Edinburgh, United Kingdom
TheBigSauce
TheBigSauce Apr. 2 at 12:25 AM
$AEHL The trolls seem worried. On squeeze watch. I’ve added more $ENTO and $GURE Nice moves today. Still holding some $YJ waking up and $BGLC on my wl.
0 · Reply
TheBigSauce
TheBigSauce Apr. 1 at 9:09 PM
$ELAB and $ENTO Nice moves today! It’s been a great week so far $AEHL 👀📈Looking good. Expecting a double $BFRG Watching closely along with $LGHL
1 · Reply
anmadam
anmadam Feb. 27 at 3:36 PM
$ENTO why hasnt the ticker updated
0 · Reply
char13
char13 Feb. 25 at 2:02 PM
$ENTO looks like a good player
0 · Reply
char13
char13 Feb. 25 at 1:44 PM
$ENTO wooaa AA ahh
0 · Reply
topstockalerts
topstockalerts Feb. 25 at 1:08 PM
$ENTO keep an eye on it for today
0 · Reply
dipmilo
dipmilo Feb. 20 at 4:25 PM
$ENTO Entero Therapeutics develops GI disease treatments. Clinical milestones drive valuation. Early-stage risk dominates.
0 · Reply
Murzeek
Murzeek Feb. 11 at 5:53 PM
$ENTO fly baby fly !!!!$
0 · Reply
Bronco6970
Bronco6970 Feb. 5 at 5:20 PM
$ENTO scam, stay away
0 · Reply
McNallieMoney
McNallieMoney Feb. 4 at 1:04 AM
$ENTO check this one out!!! Definitely worth a watch! https://youtu.be/N6wWrWcWxr8
0 · Reply
Latest News on ENTO
No data available.
TheBigSauce
TheBigSauce Apr. 2 at 12:25 AM
$AEHL The trolls seem worried. On squeeze watch. I’ve added more $ENTO and $GURE Nice moves today. Still holding some $YJ waking up and $BGLC on my wl.
0 · Reply
TheBigSauce
TheBigSauce Apr. 1 at 9:09 PM
$ELAB and $ENTO Nice moves today! It’s been a great week so far $AEHL 👀📈Looking good. Expecting a double $BFRG Watching closely along with $LGHL
1 · Reply
anmadam
anmadam Feb. 27 at 3:36 PM
$ENTO why hasnt the ticker updated
0 · Reply
char13
char13 Feb. 25 at 2:02 PM
$ENTO looks like a good player
0 · Reply
char13
char13 Feb. 25 at 1:44 PM
$ENTO wooaa AA ahh
0 · Reply
topstockalerts
topstockalerts Feb. 25 at 1:08 PM
$ENTO keep an eye on it for today
0 · Reply
dipmilo
dipmilo Feb. 20 at 4:25 PM
$ENTO Entero Therapeutics develops GI disease treatments. Clinical milestones drive valuation. Early-stage risk dominates.
0 · Reply
Murzeek
Murzeek Feb. 11 at 5:53 PM
$ENTO fly baby fly !!!!$
0 · Reply
Bronco6970
Bronco6970 Feb. 5 at 5:20 PM
$ENTO scam, stay away
0 · Reply
McNallieMoney
McNallieMoney Feb. 4 at 1:04 AM
$ENTO check this one out!!! Definitely worth a watch! https://youtu.be/N6wWrWcWxr8
0 · Reply
rockitpicks
rockitpicks Feb. 3 at 2:27 PM
$ENTO This constant absorption of stock everytime it encounters sellers is leading to a huge breakout.
0 · Reply
Tusto
Tusto Jan. 30 at 11:15 AM
$ENTO scam company Just another RS and new name will do the trick again.
0 · Reply
StarLord13
StarLord13 Jan. 2 at 4:33 PM
$ENTO Sold up here from low 3’s after this big run. Will happily reload in the 3’s again on any pullback.
0 · Reply
peepthestamp
peepthestamp Jan. 2 at 9:57 AM
$ENTO $EQ $TLRY $VFF $YTRA - Aging well 🫡
0 · Reply
rockitpicks
rockitpicks Jan. 1 at 11:06 PM
$ENTO Primed for a huge run.
0 · Reply
StarLord13
StarLord13 Dec. 30 at 10:52 PM
$ENTO @Stocktwits When will you be changing the ticker symbol on here? It’s GRDX now..
0 · Reply
BioTechHealthX
BioTechHealthX Dec. 27 at 11:09 PM
$ENTO Entero Therapeutics Inc. (NASDAQ: ENTO) is developing a recombinant lipase enzyme designed to enable digestion of fats and nutrients in cystic fibrosis and chronic pancreatitis patients. This background review explains why the market is paying attention. https://biotechhealthx.com/biotech-news/entero-therapeutics-ento-and-the-race-to-treat-exocrine-pancreatic-insufficiency/
0 · Reply
MacroCycleVector
MacroCycleVector Dec. 27 at 8:45 AM
$ENTO Momentum persists only for businesses proving consistency quarter to quarter. Efficiency gains must convert into measurable results. Credible progress tends to compress risk premiums. Future returns depend more on reliability than ambition.
0 · Reply
i_like_bb_stock
i_like_bb_stock Dec. 4 at 4:58 PM
$GRDX former $ENTO AI starting to bounce here
0 · Reply
i_like_bb_stock
i_like_bb_stock Dec. 3 at 3:33 PM
$GRDX finding bottom oversold formerly $ENTO now an AI company
0 · Reply
Klinsmann
Klinsmann Dec. 2 at 11:26 AM
$ENTO 👀
0 · Reply
fairytaleresearch
fairytaleresearch Dec. 2 at 9:32 AM
$GRDX.X ticker change from $ENTO yesterday. Got ignored in bad market. Name change follows the acqusition of Grid AI (grid edge software)
0 · Reply